Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers for Hunter Syndrome: An International, Multicenter, Observational, Longitudinal Protocol

NCT01330277 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.

NCT NCT01330277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01330277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers for Hunter Syndrome: An International, Multicenter, Observational, Longitudinal Protocol
Lead sponsor
CENTOGENE GmbH Rostock
Phase
Observational
Overall status
Terminated
Start date
August 20, 2018
Completion date
December 31, 2022
Enrollment
11 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hunter syndrome, hunter's canal syndrome, hunter's syndrome, mild form, mucopolysaccharidosis ii